Mylan (MYL) seeks approval for EpiPen with longer shelf life - Bloomberg

September 21, 2016 3:56 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Mylan (NASDAQ: MYL) seeks approval for EpiPen with longer shelf life, according to Bloomberg.

The company says that the new shelf life could be as long as 24 months.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

FDA, Trader Talk

Add Your Comment